Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes
耐 Peloruside 和 laulimalide 的人类卵巢癌细胞具有 βI-微管蛋白突变以及 βII- 和 βIII-微管蛋白同种型的表达改变
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-10-1057
Arun Kanakkanthara, Anja Wilmes, Aurora O'Brate, Daniel Escuin, Ariane Chan, Ada Gjyrezi, Janet Crawford, Pisana Rawson, Bronwyn Kivell, Peter T Northcote, Ernest Hamel, Paraskevi Giannakakou, John H Miller
